Ostatní
Návod 
AstraZeneca PLC
AZN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
266.9B
Obrat
59B
Zisk
10B
Aktiva
112B
Dluh
33B
ROE
0%
ROA
0%
PE
14
PS
2
Cena 1R
61-97
⌀ Cena
78.81
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
10-02-2026
Poslední dividenda
20-02-2026
Profil
Společnost AstraZeneca PLC, biofarmaceutická společnost, se zaměřuje na objevování, vývoj, výrobu a komercializaci léků na předpis. Mezi výrobky uváděné na trh patří Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso a Zoladex pro onkologii; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern a Xigduo/XR pro kardiovaskulární, renální Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort a Tudorza/Eklira/Bretaris pro respirační a imunologické účely a Andexxa/Ondexxxya, Kanuma, Soliris, Strensiq a Ultomiris pro vzácná onemocnění. Mezi produkty společnosti, které jsou uváděny na trh, patří také Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizofrenia bipolar disease; Nexium a Losec/Prilosec for gastroenterology; a Vaxzevria a Evusheld for covid-19. Společnost poskytuje služby primární a specializované péče lékařům prostřednictvím distributorů a místních zastupitelských úřadů ve Velké Británii, zbytku Evropy, Severní a Jižní Americe, Asii, Africe a Australasii. Společnost uzavřela dohodu o spolupráci s Regeneron Pharmaceuticals, Inc. na výzkumu, vývoji a komercializaci malých molekul léků pro obezitu; Neurimmune AG na vývoj a komercializaci NI006; Ionis Pharmaceuticals, Inc. na vývoj eplontersenu, jaterní antisenzní terapie ve fázi III vývoje pro léčbu transthyretinové amyloidózy; Proteros Biostructure GmbH na společném objevování nových malých molekul pro léčbu hematologických karcinomů; Sierra Oncology, Inc. na vývoji a komercializaci AZD5153. Společnost byla dříve známá jako Zeneca Group PLC a v dubnu 1999 změnila svůj název na AstraZeneca PLC. Společnost AstraZeneca PLC byla založena v roce 1992 a sídlí v Cambridge ve Spojeném království.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
94300
Založení
1993-05-12
Podobné společnosti
$ 126.72
+ $ 0.37
$ 46.75
+ $ 0.12
$ 46.93
+ $ 0.24
$ 50.17
+ $ 0.51
$ 86.23
- $ 0.05
$ 117.95
- $ 0.89
$ 187.28
+ $ 0.71
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 58.74 | 58.74 | 54.07 | 45.81 | 44.35 | 37.42 | 26.62 | 24.38 | 22.09 | 22.47 | 23.00 | 24.71 | 26.10 | 25.71 | 27.97 | 33.59 | 33.27 | |
| Cost of Revenues | 10.63 | 10.63 | 10.21 | 8.04 | 12.39 | 12.44 | 5.30 | 4.92 | 4.94 | 4.32 | 4.13 | 4.65 | 5.84 | 5.26 | 5.39 | 6.03 | 6.39 | |
| Gross Profit | 48.11 | 48.11 | 43.87 | 37.77 | 31.96 | 24.98 | 21.32 | 19.46 | 17.15 | 18.15 | 18.88 | 20.06 | 20.25 | 20.45 | 22.58 | 27.57 | 26.88 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 15.50 | 15.19 | 14.46 | 13.59 | 14.89 | 13.57 | 12.94 | 12.68 | 12.02 | 11.49 | |
| Cost of Revenues | 3.12 | 2.80 | 2.47 | 2.24 | 2.73 | 3.08 | 2.18 | 2.22 | 2.31 | 2.10 | |
| Gross Profit | 12.39 | 12.39 | 11.98 | 11.35 | 12.17 | 10.48 | 10.76 | 10.46 | 9.72 | 9.40 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 10.94 | 9.76 | 9.74 | 5.99 | 5.96 | 5.93 | 5.76 | 5.89 | 6.00 | 5.58 | 4.82 | 5.24 | 5.52 | 5.32 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 18.03 | 18.96 | 15.68 | 11.69 | 11.85 | 10.36 | 10.54 | 9.74 | 11.45 | 13.32 | 12.51 | 10.16 | 11.51 | 10.78 | |
| Depreciation & Amortization | 5.73 | 5.73 | 5.07 | 4.93 | 5.57 | 6.51 | 3.21 | 4.09 | 3.75 | 3.04 | 2.36 | 2.85 | 3.28 | 4.58 | 2.52 | 2.55 | 2.74 | |
| Total Operating Expenses | 34.36 | 34.36 | 33.86 | 29.58 | 28.20 | 23.92 | 16.16 | 16.27 | 13.77 | 14.47 | 13.97 | 15.95 | 18.12 | 16.74 | 14.43 | 16.25 | 15.39 | |
| Operating Income | 13.74 | 13.74 | 10.00 | 8.19 | 3.76 | 1.06 | 5.16 | 2.92 | 3.39 | 3.68 | 4.90 | 4.11 | 2.14 | 3.71 | 8.15 | 12.80 | 11.49 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.07 | 2.58 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.98 | 4.93 | ||
| Depreciation & Amortization | 1.51 | 1.55 | 1.39 | 1.28 | 0.71 | 1.82 | 1.28 | 1.26 | 0.87 | 1.28 | ||
| Total Operating Expenses | 9.41 | 8.81 | 8.48 | 7.67 | 10.13 | 8.38 | 8.01 | 7.35 | 7.71 | 7.44 | ||
| Operating Income | 2.98 | 3.58 | 3.51 | 3.67 | 2.04 | 2.11 | 2.75 | 3.12 | 1.23 | 1.95 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.36 | 0.36 | 0.35 | 0.29 | 0.10 | 0.04 | 0.09 | 0.17 | 0.14 | 0.11 | 0.07 | 0.05 | 0.08 | 0.05 | 0.53 | 0.55 | 0.52 | |
| Interest Expense | 1.69 | 1.69 | 1.68 | 1.59 | 1.35 | 1.30 | 1.31 | 1.43 | 1.42 | 1.51 | 1.38 | 1.08 | 0.96 | 0.50 | 0.96 | 0.98 | 1.03 | |
| Other Expense | -1.34 | -1.34 | -1.31 | -1.29 | -1.26 | -1.32 | -1.25 | -1.38 | -1.39 | -1.45 | -1.35 | -1.05 | -0.89 | -0.45 | -0.43 | -0.43 | -0.52 | |
| IBT | 12.40 | 12.40 | 8.69 | 6.90 | 2.50 | -0.27 | 3.92 | 1.55 | 1.99 | 2.23 | 3.55 | 3.07 | 1.25 | 3.27 | 7.72 | 12.37 | 10.98 | |
| Income Tax Expense | 2.17 | 2.17 | 1.65 | 0.94 | -0.79 | -0.38 | 0.77 | 0.32 | -0.06 | -0.64 | 0.15 | 0.24 | 0.01 | 0.70 | 1.39 | 2.35 | 2.90 | |
| Net Income | 10.23 | 10.26 | 7.04 | 5.96 | 3.29 | 0.11 | 3.20 | 1.34 | 2.16 | 3.00 | 3.50 | 2.83 | 1.23 | 2.56 | 6.30 | 9.98 | 8.05 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.12 | 0.09 | 0.07 | 0.08 | 0.06 | 0.18 | 0.10 | 0.11 | 0.07 | 0.10 | ||
| Interest Expense | 0.47 | 0.43 | 0.44 | 0.35 | 0.43 | 0.46 | 0.44 | 0.41 | 0.41 | 0.39 | ||
| Other Expense | -0.35 | -0.34 | -0.38 | -0.27 | -0.37 | -0.28 | -0.35 | -0.32 | -0.34 | -0.30 | ||
| IBT | 2.63 | 3.24 | 3.13 | 3.40 | 1.67 | 1.83 | 2.40 | 2.80 | 0.90 | 1.65 | ||
| Income Tax Expense | 0.30 | 0.71 | 0.68 | 0.48 | 0.17 | 0.40 | 0.47 | 0.62 | -0.06 | 0.27 | ||
| Net Income | 2.33 | 2.53 | 2.45 | 2.92 | 1.50 | 1.43 | 1.93 | 2.18 | 0.96 | 1.37 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $1.92 | $1.06 | $0.04 | $1.22 | $0.52 | $0.85 | $1.19 | $1.39 | $1.12 | $0.49 | $1.02 | $2.50 | $3.67 | $2.80 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $1.91 | $1.06 | $0.04 | $1.22 | $0.52 | $0.85 | $1.19 | $1.38 | $1.12 | $0.49 | $1.02 | $2.47 | $3.65 | $2.79 | |
| Shares Outstanding | 0.78 | 0.78 | 3.10 | 3.10 | 3.10 | 2.84 | 2.62 | 2.60 | 2.53 | 2.53 | 2.53 | 2.53 | 2.52 | 2.50 | 2.52 | 2.72 | 2.88 | |
| Diluted Shares Outstanding | 0.78 | 0.78 | 3.13 | 3.12 | 3.12 | 2.85 | 2.63 | 2.60 | 2.53 | 2.53 | 2.53 | 2.53 | 2.53 | 2.51 | 2.53 | 2.73 | 2.89 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.61 | $0.89 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.61 | $0.88 | ||
| Shares Outstanding | 0.78 | 0.78 | 0.78 | 0.78 | 3.10 | 3.11 | 3.11 | 3.10 | 1.55 | 1.55 | ||
| Diluted Shares Outstanding | 0.78 | 0.78 | 0.78 | 0.78 | 3.12 | 3.12 | 3.12 | 3.12 | 1.56 | 1.56 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 6.92 | 5.48 | 5.84 | 6.17 | 6.33 | 7.83 | 5.37 | 4.83 | 3.32 | 5.02 | 6.24 | 6.36 | 9.22 | 7.70 | 7.57 | 11.07 | |
| Short Term Investments | 0.16 | 0.17 | 0.02 | 0.24 | 0.07 | 0.16 | 0.85 | 0.85 | 1.23 | 0.88 | 0.61 | 0.80 | 0.80 | 0.82 | 4.25 | 1.48 | |
| Total Cash & ST Investments | 7.08 | 5.65 | 5.86 | 6.41 | 6.40 | 7.99 | 6.22 | 5.68 | 4.55 | 5.90 | 6.85 | 7.16 | 10.01 | 8.52 | 11.82 | 12.55 | |
| Accounts Receivable | 12.62 | 13.08 | 8.41 | 0.00 | 10.76 | 0.00 | 0.00 | -0.09 | -0.09 | -0.09 | -0.11 | -0.11 | -0.12 | 0.00 | 0.00 | 10.89 | |
| Inventory | 5.67 | 5.28 | 5.42 | 4.70 | 8.98 | 4.02 | 3.19 | 2.89 | 3.04 | 2.33 | 2.14 | 1.96 | 1.91 | 2.06 | 1.85 | 1.68 | |
| Other Current Assets | 0.03 | 1.79 | 5.36 | 11.49 | 0.11 | 0.00 | 0.00 | 7.11 | 5.65 | 5.12 | 7.12 | 7.70 | 8.53 | 8.46 | 9.84 | 0.01 | |
| Total Current Assets | 25.39 | 25.80 | 25.05 | 22.59 | 26.24 | 19.54 | 15.56 | 15.59 | 13.15 | 13.26 | 16.01 | 16.70 | 20.34 | 19.05 | 23.51 | 25.13 |
| Current Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 7.06 | 5.24 | 5.48 | 4.79 | 6.92 | 7.79 | 5.84 | 4.87 | 5.66 | 6.23 | |
| Short Term Investments | 0.05 | 0.17 | 0.17 | 0.13 | 0.16 | 0.18 | 0.02 | 0.24 | 0.15 | 0.23 | |
| Total Cash & ST Investments | 7.11 | 5.41 | 5.65 | 4.92 | 7.08 | 7.97 | 5.86 | 5.12 | 5.81 | 6.46 | |
| Accounts Receivable | 15.18 | 14.85 | 13.08 | 13.52 | 12.64 | 12.15 | 11.94 | 11.30 | 11.09 | 10.29 | |
| Inventory | 6.47 | 5.90 | 5.28 | 5.65 | 5.67 | 5.30 | 5.42 | 5.29 | 5.05 | 4.97 | |
| Other Current Assets | 0.20 | 0.05 | 1.79 | 0.02 | 0.03 | 0.01 | 5.36 | 0.79 | 0.88 | 0.55 | |
| Total Current Assets | 28.96 | 26.20 | 25.80 | 24.10 | 25.43 | 25.43 | 25.05 | 22.50 | 22.84 | 22.27 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 10.83 | 11.65 | 10.50 | 9.45 | 10.17 | 8.92 | 8.34 | 7.42 | 7.62 | 6.85 | 6.41 | 6.01 | 5.82 | 6.09 | 6.43 | 6.96 | |
| Goodwill | 21.06 | 21.03 | 20.05 | 19.82 | 20.00 | 11.85 | 11.67 | 11.71 | 11.83 | 11.66 | 11.87 | 11.55 | 9.98 | 9.90 | 9.86 | 9.87 | |
| Intangible Assets | 39.43 | 37.18 | 38.09 | 39.31 | 42.39 | 20.95 | 20.83 | 21.96 | 26.19 | 27.59 | 22.65 | 20.98 | 16.05 | 16.45 | 10.98 | 12.16 | |
| Long-Term Investments | 2.89 | 2.55 | 1.78 | 0.90 | 1.17 | 0.99 | 0.61 | 0.07 | -0.19 | -0.06 | -0.07 | -0.23 | -0.52 | -0.62 | -4.05 | -1.27 | |
| Other Long-Term Assets | 0.00 | 0.46 | 0.93 | 1.15 | 1.07 | 1.05 | 1.65 | 1.52 | 2.58 | 2.13 | 1.97 | 2.37 | 3.03 | 1.56 | 4.59 | 1.81 | |
| Total Long-Term Assets | 78.95 | 78.21 | 76.07 | 73.89 | 79.12 | 47.19 | 45.81 | 45.06 | 50.20 | 49.26 | 44.12 | 41.90 | 35.56 | 34.49 | 29.32 | 31.00 | |
| Total Assets | 104.34 | 104.04 | 101.12 | 96.48 | 105.36 | 66.73 | 61.38 | 60.65 | 63.35 | 62.53 | 60.12 | 58.60 | 55.90 | 53.53 | 52.83 | 56.13 |
| Long-Term Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 13.23 | 12.30 | 11.65 | 11.51 | 10.83 | 10.55 | 10.50 | 9.70 | 9.62 | 9.60 | |
| Goodwill | 21.22 | 21.13 | 21.03 | 21.14 | 21.06 | 19.85 | 20.05 | 19.94 | 19.96 | 20.00 | |
| Intangible Assets | 37.93 | 37.55 | 37.18 | 39.39 | 39.43 | 38.83 | 38.09 | 37.69 | 38.33 | 39.29 | |
| Long-Term Investments | 4.85 | 3.04 | 2.55 | 3.37 | 2.90 | 2.64 | 1.66 | 1.05 | 1.00 | 1.00 | |
| Other Long-Term Assets | 0.00 | -0.01 | 0.46 | 0.01 | 0.00 | 0.02 | 1.05 | 1.16 | 1.06 | 1.03 | |
| Total Long-Term Assets | 83.48 | 80.11 | 78.21 | 80.77 | 78.95 | 76.70 | 76.07 | 73.59 | 73.70 | 74.42 | |
| Total Assets | 112.42 | 106.25 | 104.04 | 104.92 | 104.34 | 102.29 | 101.12 | 96.09 | 96.54 | 96.69 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 20.46 | 3.64 | 3.27 | 19.04 | 18.94 | 15.79 | 13.99 | 12.84 | 11.64 | 10.49 | 11.66 | 11.89 | 10.36 | 9.22 | 8.98 | 8.66 | |
| Short-Term Debt | 5.36 | 2.50 | 6.39 | 5.54 | 1.89 | 2.39 | 2.01 | 1.75 | 2.25 | 2.31 | 0.92 | 2.45 | 1.79 | 0.90 | 1.99 | 0.13 | |
| Other Current Liabilities | 1.22 | 20.33 | 18.66 | 1.71 | 1.76 | 2.14 | 2.12 | 12.82 | 10.53 | 9.96 | 10.48 | 11.39 | 11.76 | 10.32 | 11.61 | 0.01 | |
| Current Liabilities | 28.57 | 27.87 | 30.54 | 26.29 | 22.59 | 20.31 | 18.12 | 16.29 | 16.38 | 15.26 | 14.87 | 17.33 | 16.05 | 13.90 | 15.75 | 16.79 |
| Current Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 23.99 | 22.54 | 22.47 | 21.68 | 20.46 | 19.70 | 3.27 | 18.56 | 17.73 | 17.22 | |
| Short-Term Debt | 6.85 | 3.41 | 2.50 | 1.57 | 5.36 | 6.33 | 6.39 | 6.51 | 5.68 | 4.69 | |
| Other Current Liabilities | 1.27 | 3.18 | 1.50 | 1.20 | 1.22 | 1.24 | 18.81 | 2.36 | 1.77 | 1.75 | |
| Current Liabilities | 33.54 | 29.13 | 27.87 | 25.93 | 28.57 | 28.90 | 30.54 | 28.59 | 26.38 | 24.86 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 27.23 | 27.62 | 23.22 | 23.69 | 28.89 | 17.99 | 16.22 | 17.36 | 15.56 | 14.50 | 14.14 | 8.40 | 8.59 | 9.41 | 7.34 | 9.47 | |
| Capital Leases | 0.95 | 1.45 | 1.13 | 0.95 | 0.99 | 0.68 | 0.68 | 0.00 | 0.01 | 0.09 | 0.10 | 0.11 | 0.10 | 0.08 | 0.00 | 0.00 | |
| Def. Tax Liability | 3.33 | 3.31 | 2.84 | 2.94 | 6.21 | 2.92 | 2.49 | 3.29 | 4.00 | 3.96 | 2.73 | 1.80 | 2.83 | 2.58 | 2.74 | 3.15 | |
| Total Liabilities | 64.74 | 63.16 | 61.95 | 59.43 | 66.08 | 51.09 | 46.78 | 46.61 | 46.71 | 45.86 | 41.62 | 38.95 | 32.65 | 29.58 | 29.36 | 32.72 |
| Long-Term Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 25.99 | 27.89 | 27.62 | 29.99 | 28.17 | 28.22 | 23.22 | 22.97 | 25.05 | 27.65 | |
| Capital Leases | 1.63 | 1.55 | 1.45 | 1.42 | 1.24 | 1.24 | 1.13 | 0.98 | 0.95 | 0.96 | |
| Def. Tax Liability | 3.62 | 3.55 | 3.31 | 3.57 | 3.33 | 2.62 | 2.84 | 2.75 | 2.80 | 2.80 | |
| Total Liabilities | 67.61 | 65.12 | 63.16 | 64.12 | 64.74 | 64.79 | 61.95 | 58.87 | 59.13 | 60.88 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.33 | 0.33 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.31 | 0.32 | 0.35 | |
| Retained Earnings | 1.85 | 3.16 | 4.52 | -0.57 | 1.71 | 5.30 | 2.81 | 5.68 | 8.22 | 8.14 | 11.83 | 13.03 | 16.96 | 17.96 | 17.89 | 18.27 | |
| Comprehensive Income | 2.08 | 0.00 | -0.95 | 0.00 | 0.00 | 0.00 | 0.00 | -7.22 | -7.02 | -6.60 | -7.44 | -7.73 | -9.09 | -8.98 | -8.89 | -8.63 | |
| Total Common Equity | 39.51 | 40.79 | 39.14 | 37.04 | 39.27 | 15.62 | 13.13 | 12.47 | 14.96 | 14.85 | 18.49 | 19.63 | 23.22 | 23.74 | 23.25 | 23.21 |
| Total Common Equity | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | |
| Retained Earnings | 7.02 | 3.36 | 3.16 | 3.14 | 1.85 | -0.21 | 1.50 | -0.43 | -0.23 | -1.83 | |
| Comprehensive Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.62 | 2.08 | 2.08 | 2.07 | |
| Total Common Equity | 44.72 | 41.04 | 40.79 | 40.72 | 39.51 | 37.45 | 39.14 | 37.20 | 37.39 | 35.79 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 33.53 | 30.11 | 28.62 | 29.23 | 30.78 | 20.38 | 18.23 | 19.11 | 17.81 | 16.81 | 15.05 | 10.84 | 10.38 | 10.31 | 9.33 | 9.60 | |
| Book Value | 39.60 | 40.87 | 39.17 | 37.06 | 39.29 | 15.64 | 14.60 | 14.04 | 16.64 | 16.67 | 18.51 | 19.65 | 23.25 | 23.95 | 23.47 | 23.41 |
| Other | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.06 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Book Value | 44.72 | 41.04 | 40.79 | 40.72 | 39.51 | 37.45 | 39.14 | 37.20 | 37.39 | 35.79 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 6.66 | 10.23 | 8.69 | 6.90 | 2.50 | -0.27 | 3.92 | 1.55 | 1.99 | 2.23 | 3.55 | 3.07 | 1.25 | 3.27 | 7.72 | 12.37 | 10.98 | |
| Depreciation & Amortization | 4.69 | 5.73 | 5.07 | 4.93 | 5.48 | 6.53 | 3.15 | 3.76 | 3.75 | 3.04 | 2.36 | 2.85 | 3.28 | 4.58 | 2.52 | 2.55 | 2.74 | |
| Stock-Based Compensation | 0.58 | 0.00 | 0.00 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change Working Capital | 0.46 | -1.16 | -0.89 | 0.30 | 3.76 | 2.02 | 0.36 | -0.35 | -0.64 | -0.05 | 0.93 | -0.05 | 2.51 | 0.17 | -0.71 | -0.90 | 0.08 | |
| Change In Accounts Receivable | -1.43 | 0.00 | -1.62 | -1.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 1.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change In Inventories | -0.67 | 0.00 | -0.13 | -0.67 | 3.94 | 1.58 | -0.62 | -0.32 | -0.01 | -0.55 | -0.34 | -0.32 | 0.11 | 0.14 | -0.15 | -0.26 | 0.09 | |
| Other Non-cash Items | 4.53 | -0.22 | -1.00 | -2.37 | -1.93 | -2.32 | -2.63 | -2.00 | -2.49 | -1.64 | -2.69 | -2.55 | 0.02 | -0.62 | -2.58 | -6.20 | -3.12 | |
| Cash from Operations | 11.27 | 0.00 | 0.00 | 10.35 | 9.81 | 5.96 | 4.80 | 2.97 | 2.62 | 3.58 | 4.15 | 3.32 | 7.06 | 7.40 | 6.95 | 7.82 | 10.68 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.36 | 2.53 | 3.13 | 2.92 | 1.67 | 1.83 | 2.40 | 2.80 | 0.90 | 1.65 | |
| Depreciation & Amortization | 1.53 | 1.55 | 1.39 | 1.28 | 0.71 | 1.82 | 1.28 | 1.26 | 0.87 | 1.28 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.58 | 0.00 | |
| Change Working Capital | -1.23 | 0.84 | -0.35 | -0.43 | -0.35 | 0.04 | -0.13 | -0.46 | 0.15 | 0.90 | |
| Change In Accounts Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.43 | 0.00 | |
| Change In Accounts Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.39 | 0.00 | |
| Change In Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.67 | 0.00 | |
| Other Non-cash Items | -0.23 | 0.22 | -0.79 | -0.06 | 0.88 | -0.30 | -0.46 | -1.11 | 0.46 | -0.72 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.38 | 3.11 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.10 | -2.81 | -1.92 | -1.36 | -2.57 | -2.20 | -2.61 | -2.46 | -1.37 | -1.62 | -2.31 | -2.79 | -2.75 | -2.06 | -4.62 | -1.30 | -2.42 | |
| Acquisitions | -3.76 | -1.23 | -3.93 | -1.18 | -1.06 | -9.43 | -0.83 | -0.78 | -0.54 | -1.96 | -2.90 | -3.07 | -4.53 | -1.16 | -1.19 | 1.77 | -0.35 | |
| Investments | -0.32 | 0.00 | -0.10 | -0.14 | -0.16 | -0.18 | -0.12 | -0.01 | -0.10 | -0.44 | -0.40 | -0.06 | -0.13 | -0.09 | -0.05 | -2.75 | -0.03 | |
| Sales of Investment | 0.14 | 0.00 | 0.11 | 0.13 | 0.04 | 0.11 | 2.13 | 0.21 | 0.43 | 0.07 | 0.00 | 0.38 | 0.09 | 0.17 | 3.66 | -0.36 | 0.01 | |
| Other Investing Activities | 0.06 | 0.00 | 0.00 | -1.52 | 0.79 | 0.65 | 1.14 | 2.39 | 2.54 | 1.62 | 1.64 | 1.30 | 0.29 | 0.25 | 0.33 | 0.61 | 0.46 | |
| Cash from Investing | -7.79 | 0.00 | 0.00 | -4.06 | -2.96 | -11.06 | -0.29 | -0.66 | 0.96 | -2.33 | -3.97 | -4.24 | -7.03 | -2.89 | -1.86 | -2.02 | -2.34 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.30 | -0.69 | -0.66 | -0.43 | -0.71 | -0.42 | -0.38 | -1.61 | -0.95 | -0.88 | |
| Acquisitions | -0.26 | -0.33 | -0.27 | -0.36 | -0.27 | -0.28 | -2.30 | -0.94 | -0.30 | -0.27 | |
| Investments | -0.01 | 0.00 | -0.19 | 0.00 | 0.00 | -0.03 | 0.03 | 0.00 | -0.02 | -0.10 | |
| Sales of Investment | 0.01 | 0.00 | 0.11 | 0.00 | -0.03 | 0.05 | 0.08 | 0.01 | 0.10 | -0.07 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.09 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.08 | -1.22 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -8.64 | 0.00 | 0.00 | -0.97 | -1.27 | -4.76 | -1.61 | -2.02 | -1.50 | -1.75 | -0.30 | -1.51 | -0.75 | -0.01 | -1.75 | -0.05 | -1.75 | |
| Debt Issued | 12.33 | 30.11 | 1.49 | 0.36 | -0.28 | 15.16 | 3.76 | 1.13 | 2.80 | 2.75 | 2.06 | 5.72 | 1.22 | 0.07 | 2.73 | -0.22 | 11.34 | |
| Issuance of Common Stock | 0.04 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 3.53 | 0.03 | 0.04 | 0.05 | 0.04 | 0.28 | 0.48 | 0.43 | 0.41 | 0.49 | |
| Repurchase of Common Stock | -1.69 | -0.72 | 0.00 | 0.00 | -0.92 | 12.41 | 3.05 | 0.31 | 2.97 | 2.31 | 2.78 | 5.89 | 1.40 | -0.03 | -2.64 | -6.02 | -2.60 | |
| Dividends Paid | -4.46 | 0.00 | 0.00 | -4.48 | -4.36 | -3.86 | -3.57 | -3.59 | -3.48 | -3.52 | -3.56 | -3.49 | -3.52 | -3.46 | -3.67 | -3.76 | -3.36 | |
| Other Financing Activities | 0.76 | 0.00 | 0.00 | -1.15 | -0.30 | -0.18 | -0.10 | 0.00 | -0.07 | -0.02 | -0.29 | -0.05 | -0.12 | -0.04 | 2.70 | 0.10 | 0.00 | |
| Cash from Financing | -2.21 | 0.00 | 0.00 | -6.57 | -6.82 | 3.65 | -2.20 | -1.77 | -2.04 | -2.94 | -1.32 | 0.88 | -2.71 | -3.05 | -4.92 | -9.32 | -7.22 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.24 | -1.21 | |
| Debt Issued | 0.00 | 32.84 | 1.55 | 1.18 | -1.45 | -1.97 | -1.02 | 5.93 | 0.28 | -0.05 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | |
| Repurchase of Common Stock | -0.20 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.41 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.07 | -0.11 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.29 | -2.73 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 1.24 | 0.27 | -0.21 | -0.35 | -0.06 | -1.51 | 2.32 | 0.55 | 1.50 | -1.75 | -1.13 | -0.11 | -2.83 | 1.40 | 0.16 | -3.55 | 1.15 | |
| Closing Cash Balance | 6.92 | 5.70 | 5.43 | 5.64 | 5.98 | 6.04 | 7.55 | 5.22 | 4.67 | 3.17 | 4.92 | 6.05 | 6.16 | 9.00 | 7.60 | 7.43 | 10.98 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -2.41 | 1.05 | 1.83 | -0.22 | 0.99 | -2.24 | -1.02 | 2.06 | 1.02 | -0.85 | |
| Closing Cash Balance | 5.72 | 8.08 | 7.03 | 5.21 | 5.43 | 4.44 | 6.68 | 7.69 | 5.64 | 4.62 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 7.17 | 11.77 | 7.28 | 6.57 | 7.24 | 3.76 | 2.19 | 0.51 | 1.25 | 1.96 | 1.83 | 0.54 | 4.31 | 5.34 | 2.33 | 6.52 | 8.26 | |
| Real Free Cash Flow | 6.59 | 11.77 | 7.28 | 5.99 | 7.24 | 3.76 | 2.19 | 0.51 | 1.25 | 1.96 | 1.83 | 0.54 | 4.31 | 5.34 | 2.33 | 6.52 | 8.26 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.38 | 4.45 | 1.46 | 3.28 | 1.95 | 2.03 | 2.42 | 0.88 | 1.43 | 2.24 | |
| Real Free Cash Flow | 1.38 | 4.45 | 1.46 | 3.28 | 1.95 | 2.03 | 2.42 | 0.88 | 0.86 | 2.24 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 14 | 58.5 | 86.1 |
| P/S | 2.4 | 3.8 | 578 |
| P/B | 3.2 | 5.2 | 582.9 |
| P/FCF | 13.6 | 33.1 | 10581.1 |
| Market cap | $266.9 | $231.9 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 25.1 % | 0 % |
| Debt to Income | 321.2 % | 888.9 % | 0 % |
| Debt to Free cash flow | 310.6 % | 27.2 % | 0 % |
| Interest expense percentage | 12.3 % | 76.8 % | 7 % |
| Current ratio | 0.9 | 1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 22.9 % | 18.2 % | 0 % |
| ROA | 9.1 % | 6 % | 0 % |
| CapEx to Revenue | 5.2 % | 8.3 % | 10.5 % |
| RaD to Revenue | 0 % | 21.2 % | 0 % |
| ROEM | 29,049,950.5 | 379675.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 81.9 % | 78.9 % | 77.7 % |
| Operating margin | 23.4 % | 18.9 % | 29.4 % |
| Net margin | 17.4 % | 13.5 % | 22.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 5.6 % | 0 % |
| Dividend payout percentage | 0 % | 160.8 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 3,124.0 mil | 2,643.2 mil |
| Employee count | 2.0 tis | 9.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
